Artificial intelligence in the diagnosis and treatment of prostate cancer based on PSMA PET

VernacularTitle:基于PSMA PET的人工智能在前列腺癌诊治中的应用进展
Author: Dai-Yun PENG ¹ ; Jing-Yu FU ; Fan YANG ; Jiang-Yan LIU
Author Information

1. 兰州大学第二医院核医学科,甘肃兰州 730030
Keywords: prostate cancer; artificial intelligence; prostate-specific membrane antigen; positron emission tomography
From: Medical Journal of Chinese People's Liberation Army 2025;50(10):1250-1255
CountryChina
Language:Chinese
Abstract: Prostate-specific membrane antigen(PSMA)positron emission tomography(PET)is currently a precise diagnostic imaging technology for prostate cancer(PCa).Artificial intelligence(AI)technologies,particularly machine learning and deep learning algorithms,when combined with PSMA PET,showed extensive potential applications in various aspects of PCa management.These include the diagnosis and differential diagnosis of primary tumors,staging,recurrence detection,and treatment planning for PCa.At present,a few AI models have received clinical approval.This paper reviews the application progress of AI combined with PSMA PET in the diagnosis and treatment of PCa,explores the current limitations of AI technologies in clinical practice,and aim to provide references to future diagnosis and treatment studies for PCa.